Canada markets closed
  • S&P/TSX

    17,396.56
    +45.22 (+0.26%)
     
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • DOW

    29,910.37
    +37.90 (+0.13%)
     
  • CAD/USD

    0.7698
    +0.0016 (+0.21%)
     
  • CRUDE OIL

    45.53
    -0.18 (-0.39%)
     
  • BTC-CAD

    22,856.45
    -6.41 (-0.03%)
     
  • CMC Crypto 200

    333.27
    -4.23 (-1.25%)
     
  • GOLD FUTURES

    1,788.10
    -23.10 (-1.28%)
     
  • RUSSELL 2000

    1,855.27
    +10.25 (+0.56%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • NASDAQ

    12,205.85
    +111.44 (+0.92%)
     
  • VOLATILITY

    20.84
    -0.41 (-1.93%)
     
  • FTSE

    6,367.58
    +4.65 (+0.07%)
     
  • NIKKEI 225

    26,644.71
    +107.40 (+0.40%)
     
  • CAD/EUR

    0.6431
    -0.0016 (-0.25%)
     

James E. Wagner Cultivation Corporation Announces Stock Option Grants

KITCHENER, Ontario, Feb. 27, 2020 (GLOBE NEWSWIRE) -- James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX VENTURE: JWCA), announced today the grant of incentive stock options as compensation to each of its independent directors. Each of the three independent directors of the Corporation has been granted options to purchase 50,000 common shares (“Shares”) of the Corporation at an exercise price of $0.17 per share. These options vest on the date of grant and expire on February 25, 2025. A total of 150,000 Shares has been reserved for issuance in connection with the stock option grants. The stock option grants remain subject to approval of the TSX Venture Exchange.

About James E. Wagner Cultivation Corporation
James E. Wagner Cultivation Corporation’s wholly owned subsidiary is a Licensed Producer under the Cannabis Regulations, formerly the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis using an advanced and proprietary aeroponic platform named GrowthSTORM™. JWC began as a collective of patients and growers under the Marihuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC is a family-founded company with deep roots planted in the local community. JWC’s operations are based in Kitchener, Ontario. Learn more at www.jwc.ca.

Notice regarding forward-looking statements:

This press release contains statements including forward-looking information for purposes of applicable securities laws (“forward-looking statements”) about JWC and the issuance of stock options and common shares issuable upon the exercise thereof. The forward-looking statements can be identified by the use of such words as “will”, “expected”, “approximately”, “may”, “could”, “would” or similar words and phrases. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those implied in the forward-looking statements. For example, risks include risks regarding the cannabis industry, economic factors, the equity markets generally, building permit related risks and risks associated with growth and competition as well as the risks identified in the Corporation’s Filing Statement available under the Corporation’s profile at www.sedar.com. Although JWC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and are based on current assumptions which management believes to be reasonable. The Corporation disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information about this release, please contact
Nathan Woodworth, President & CEO of JWC
Email: nathan@jwc.ca
Phone: (519) 594-0144 x421
OR

Investor Relations
Jonathan Leuchs
CMA
(949) 432-7758
JWCA@cma.team